Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Undercover investigation shows plight of dogs, other animals in Indiana testing laboratory

Humane Society of the United States (PRNewsfoto/Humane Society of the United ...)

News provided by

Humane Society Legislative Fund; Humane Society of the United States

Apr 21, 2022, 07:30 ET

Share this article

Share toX

Share this article

Share toX

The Humane Society of the United States and Humane Society Legislative Fund are calling on the lab to release more than 80 beagles still being tested on

WASHINGTON, April 21, 2022 /PRNewswire/ -- Today, the Humane Society of the United States revealed the results of an approximately seven-month undercover investigation at Inotiv, an animal testing laboratory in Indiana where thousands of animals, including dogs, primates, pigs, mice and rats are killed every year. The investigation reveals the suffering and death of these animals for toxicity testing of drugs.

Continue Reading

The Humane Society of the United States and Humane Society Legislative Fund are calling on the Food and Drug Administration and pharmaceutical companies to replace animals with more effective non-animal testing approaches that will better serve humans while sparing animals.

"We are calling for the release of beagles we know are suffering in the lab today..."

Post this

From August 2021 to March 2022, an undercover investigator was employed at the facility and assigned to work on more than 70 toxicity studies commissioned by over two dozen pharmaceutical companies involving more than 6,000 animals. Some of the egregious findings revealed throughout the investigation include:

  • At least two primates accidentally hanged themselves in restraint chairs.
  • Dogs continued to be given doses of substances even when they were vomiting, shaking and had high fevers and labored breathing.
  • The laboratory veterinarian did not always assess or treat severely sick dogs and primates, some wailing in pain, due to personal inconvenience.

The animals spent their days behind bars and were subjected to painful procedures such as force-feeding substances via stomach tubes, injections and multiple blood draws. Young primates were often held in restraint chairs for long periods of time during these procedures. Most of the animals were killed at the end of the studies, as is typical for any drug testing.

Close to 90% of drugs tested on animals ultimately fail in human trials, with approximately half of those failures due to unanticipated human toxicity, despite no toxicity having been observed in animals. An example unfolded during the investigation when Aligos Therapeutics ended pursuit of a drug being tested on mice and primates at Inotiv while the HSUS investigator was there. The biopharmaceutical company halted the tests because of unexpected toxicity in a human clinical trial. One person was hospitalized, and three others suffered from adverse effects.

There is evidence that non-animal approaches, such as organ-chip technologies, artificial intelligence, 3D printing and various other approaches, alone or in combination, provide superior results that will ultimately improve drug success rates for humans while sparing animals. The largest organ-chip study conducted to date demonstrated that liver chips detected toxicity in almost seven out of every eight drugs that proved toxic in human patients even after animal tests did not reveal that the drugs were toxic in the animal models.

Most urgently, 80 beagle puppies are still used in toxicity testing that involves forcing them to ingest a drug via stomach tube every day for months on end. The first wave of dogs is scheduled to be killed in mid-May and the HSUS and HSLF are calling for their immediate release from the laboratory. Crinetics Pharmaceuticals commissioned Inotiv to conduct these tests. The HSUS and HSLF are also calling for the release of two dogs who are used by workers to practice procedures, known as stock animals. The dogs have been used for practice procedures for years.

"The disturbing findings at this facility cannot be ignored. We are calling for the release of beagles we know are suffering in the lab today and soon to be euthanized, but that is just the start of our work," said Kitty Block, CEO and president of the Humane Society of the United States. "We must tackle the root cause of this suffering. This seems to be one of the only areas in science where failure to innovate and make change is accepted and, at times, encouraged. It is our hope that sharing the plight of these animals will accelerate FDA and pharmaceutical industry changes to replace outdated animal tests with superior modern technologies." 

"Our federal government needs to invest in good science in the form of effective and humane non-animal test methods to replace these tragic animal tests. In many cases non-animal tests are more reliable, faster and more cost effective than the existing animal methods most commonly accepted by our federal government," said Sara Amundson, president of the Humane Society Legislative Fund. "It's time for the FDA to accelerate the move away from animal testing within the regulated sector. We need to ensure a better future for both animals and people."

Inotiv is one of hundreds of laboratories carrying out experiments on animals. It is one of the largest and continues to grow.

The company's dog breeding facility in Cumberland, Virginia, has been cited for numerous violations of the Animal Welfare Act, prompting the Virginia legislature to pass five bills to increase protection for animals at laboratory breeding facilities, recently signed into law by Gov. Glenn Youngkin.

In addition to the release of the 82 dogs, HSUS and HSLF are calling on the company to seek out alternatives, stop testing on all animals in this lab and find appropriate placement for them.

Full investigation report

Photos and video 

Founded in 1954, the Humane Society of the United States fights the big fights to end suffering for all animals. Together with millions of supporters, we take on puppy mills, factory farms, trophy hunts, animal testing and other cruel industries. With our affiliates, we rescue and care for tens of thousands of animals every year through our animal rescue team's work and other hands-on animal care services. We fight all forms of animal cruelty to achieve the vision behind our name: A humane society. 

Learn more about our work at humanesociety.org. Subscribe to Kitty Block's blog, A Humane World. Follow the HSUS Media Relations department on Twitter. Read the award-winning All Animals magazine. Listen to the Humane Voices Podcast. 

Humane Society Legislative Fund works to pass animal protection laws at the state and federal level, to educate the public about animal protection issues and support humane candidates for office. Formed in 2004, HSLF is incorporated under section 501(c)(4) of the Internal Revenue Code as a separate lobbying affiliate of the Humane Society of the United States. 

Visit us on the web at hslf.org, read our blog at hslf.org/blog and follow us on Facebook

SOURCE Humane Society Legislative Fund; Humane Society of the United States

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.